|

EDV-GC Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Engeneic Pty Limited1

Indications

  • Pancreatic Cancer Metastatic1
  • PDAC - Pancreatic Ductal Adenocarcinoma1
  • Cancer1

El Segundo, California1 trial

A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer

Chan Soon-Shiong Institute for Medicine

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.